In summary, we are making significant strides in advancing BOT/BAL and positioning Agenus for long-term success. I'll now ...
"I think the overriding thing is going to be the expiration of the [ACA] subsidies that we've talked a lot about at the end of the year," said Loren Duggan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback